Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx only, Mfd for: Watson Laboratories, Inc., Corona, CA 92880, Mfd by: Patheon Pharmaceuticals, Inc., Cincinnati, OH 43215, NDC 0591-0844-15

Recall Number: D-1058-2017

Firm: Teva Pharmaceuticals USA

Classification: Class III

Status: Terminated

Report Date: 20170816

Initiation Date: 20170802

Termination Date: 20180228

Reason for Recall

Failed Moisture Limits: out of specification test results for water content obtained during stability testing.

Product Description

Glipizide Extended-Release Tablets (anti-diabetic agent), 5 mg, packaged in 30-unit dose blister pack per carton, Rx only, Mfd for: Watson Laboratories, Inc., Corona, CA 92880, Mfd by: Patheon Pharmaceuticals, Inc., Cincinnati, OH 43215, NDC 0591-0844-15